中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
9期
1292-1293
,共2页
乳腺肿瘤%早期诊断%乳房切除术,区段
乳腺腫瘤%早期診斷%乳房切除術,區段
유선종류%조기진단%유방절제술,구단
Breast neoplasms%Early Diagnosis%Masleclomy,segmental
目的 探讨乳腺癌患者早期保乳手术的临床疗效.方法 对128例保乳手术的乳腺癌早期患者自手术当天开始计算,随访30 ～ 80个月,中位随访时间64个月,统计治疗结果及术后美容效果.结果 随访率为100％,总生存率为95.30％,1年生存率为100.00％(128/128),3年生存率为98.44％(126/128),5年生存率为95.31％(122/128).术后随访死亡6例,3例死于肝转移,2例死于肺转移,l例死于非肿瘤原因.局部复发率2.34％(3/128),腋淋巴结复发率1.56％(2/128).复发时间平均为术后3年2个月,远处转移率3.91％(5/128).术后128例保乳患者美容评价,优71例(55.47％),良55例(42.97％),差2例(1.56％).患者接受度为98％.结论 保乳手术解决了女性对美的追求,提高了患者生存质量.
目的 探討乳腺癌患者早期保乳手術的臨床療效.方法 對128例保乳手術的乳腺癌早期患者自手術噹天開始計算,隨訪30 ～ 80箇月,中位隨訪時間64箇月,統計治療結果及術後美容效果.結果 隨訪率為100％,總生存率為95.30％,1年生存率為100.00％(128/128),3年生存率為98.44％(126/128),5年生存率為95.31％(122/128).術後隨訪死亡6例,3例死于肝轉移,2例死于肺轉移,l例死于非腫瘤原因.跼部複髮率2.34％(3/128),腋淋巴結複髮率1.56％(2/128).複髮時間平均為術後3年2箇月,遠處轉移率3.91％(5/128).術後128例保乳患者美容評價,優71例(55.47％),良55例(42.97％),差2例(1.56％).患者接受度為98％.結論 保乳手術解決瞭女性對美的追求,提高瞭患者生存質量.
목적 탐토유선암환자조기보유수술적림상료효.방법 대128례보유수술적유선암조기환자자수술당천개시계산,수방30 ～ 80개월,중위수방시간64개월,통계치료결과급술후미용효과.결과 수방솔위100％,총생존솔위95.30％,1년생존솔위100.00％(128/128),3년생존솔위98.44％(126/128),5년생존솔위95.31％(122/128).술후수방사망6례,3례사우간전이,2례사우폐전이,l례사우비종류원인.국부복발솔2.34％(3/128),액림파결복발솔1.56％(2/128).복발시간평균위술후3년2개월,원처전이솔3.91％(5/128).술후128례보유환자미용평개,우71례(55.47％),량55례(42.97％),차2례(1.56％).환자접수도위98％.결론 보유수술해결료녀성대미적추구,제고료환자생존질량.
Objective To explore the clinical efficacy of early breast cancer patients underwent breast-conserving surgery with postoperative chemotherapy and radiotherapy.Methods A retrospective analysis of 128 early breast cancer patients underwent routine breast-conserving surgery was conducted.The clinical effect and cosmetic results were analyzed by the follow-up results of 128 cases.Results (1) The 5-year follow-up rate was 100％,overall survival rate was 95.3％,1-year survival rate was 100％ (128/128) ;3-year survival rate was 98.4％ (126/128) ;5-year survival rate was 95.30％ (122/128).Postoperative follow-up 6 patients died,3 patients died of liver metastases,2 patients died of lung metastases,1 patient died of non-cancerous reasons.The local recurrence rate was 2.34％ (3/128),axillary lymph node recurrence rate was 1.56％ (2/128).The average recurrence time was three years and two months after operation,distant metastasis rate was 3.91％ (5/128).(2) Beauty evaluations of 128 patients with breast-conserving surgery were excellent in 71 cases (55.5％),good in 55 cases (43.0％),and poor'in 2 cases (1.6％).Good,acceptable as acceptance criteria,the acceptance rate was 98％.Conclusion Breast-conserving surgery is not only to a certain extent to solve the pursuit of female beauty,but also improve their quality of life.But only the complete elimination of residual lesions in order to truly ensure that no recurrence of tumor.Therefore,the appropilate survival rate of patients for radiotherapy and chemotherapy can be extended so that the patient's breast to maintain a good shape.Breast-conserving surgery combined with radiotherapy and chemotherapy is superior to the modified radical surgery,and popularization in the hospital.
